6-KThe Wire
Telix Pharmaceuticals Ltd files 6-K
Filed Apr 9, 2026 · 2mo ago · Accession 0001628280-26-024320
Plain English
Telix Pharmaceuticals Limited announced the appointment of two new directors to its board, strengthening its governance and strategic oversight. The company also noted that information in this report is incorporated into its existing SEC registration statements.
Filing details
- Company
- Telix Pharmaceuticals Ltd
- Ticker
- TLX
- CIK
- 2007191
- Form type
- 6-K
- Filing date
- Apr 9, 2026
- Report date
- Apr 9, 2026
- Document
- telix-6kfornedappt8april26.htm
- Size
- 718 KB
More from TLX
6-KThe WireJul 2, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSMay 21, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 23, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 21, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 20, 20266-KThe WireApr 14, 2026